tradingkey.logo

Transmedics Group Inc

TMDX
127.670USD
+6.600+5.45%
Cierre 12/19, 16:00ETCotizaciones retrasadas 15 min
4.36BCap. mercado
47.17P/E TTM

Transmedics Group Inc

127.670
+6.600+5.45%

Más Datos de Transmedics Group Inc Compañía

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Información de Transmedics Group Inc

Símbolo de cotizaciónTMDX
Nombre de la empresaTransmedics Group Inc
Fecha de salida a bolsaMay 02, 2019
Director ejecutivoHassanein (Waleed H)
Número de empleados728
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 02
Dirección200 Minuteman Road
CiudadANDOVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01810
Teléfono19785520900
Sitio Webhttps://www.transmedics.com/
Símbolo de cotizaciónTMDX
Fecha de salida a bolsaMay 02, 2019
Director ejecutivoHassanein (Waleed H)

Ejecutivos de Transmedics Group Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
481.61K
-8.98%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
177.21K
+1.22%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.13K
--
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
7.04K
-44.49%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
+110.86%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
4.06K
+110.86%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
+110.86%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
331.00
-97.93%
Mr. Anil Ranganath
Mr. Anil Ranganath
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Mr. Edwin M. Kania, Jr.
Mr. Edwin M. Kania, Jr.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
481.61K
-8.98%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
177.21K
+1.22%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.13K
--
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
7.04K
-44.49%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
+110.86%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
4.06K
+110.86%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
OCS Liver net revenue
116.11M
74.26%
OCS Heart net revenue
35.67M
22.81%
OCS Lung net revenue
4.58M
2.93%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
152.19M
97.34%
All other countries
4.16M
2.66%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
OCS Liver net revenue
116.11M
74.26%
OCS Heart net revenue
35.67M
22.81%
OCS Lung net revenue
4.58M
2.93%

Estadísticas de accionistas

Actualizado: mar., 25 de nov
Actualizado: mar., 25 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.86%
Fidelity Management & Research Company LLC
13.45%
The Vanguard Group, Inc.
10.53%
State Street Investment Management (US)
3.74%
Two Sigma Investments, LP
3.10%
Otro
55.32%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.86%
Fidelity Management & Research Company LLC
13.45%
The Vanguard Group, Inc.
10.53%
State Street Investment Management (US)
3.74%
Two Sigma Investments, LP
3.10%
Otro
55.32%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
71.86%
Investment Advisor/Hedge Fund
23.66%
Hedge Fund
7.08%
Research Firm
4.62%
Individual Investor
2.95%
Bank and Trust
2.15%
Pension Fund
1.35%
Sovereign Wealth Fund
0.18%
Insurance Company
0.10%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
762
37.62M
110.09%
-8.17M
2025Q2
746
42.27M
124.01%
-2.30M
2025Q1
751
42.32M
125.08%
-2.32M
2024Q4
728
40.09M
119.11%
-642.74K
2024Q3
673
39.30M
117.10%
+1.37M
2024Q2
615
36.53M
110.85%
-3.27M
2024Q1
544
37.44M
113.97%
-4.28M
2023Q4
512
38.18M
116.94%
-3.46M
2023Q3
482
38.42M
117.77%
-240.92K
2023Q2
462
35.43M
108.88%
-81.81K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
4.73M
13.87%
-97.24K
-2.02%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.63M
13.57%
-32.85K
-0.71%
Jun 30, 2025
The Vanguard Group, Inc.
3.59M
10.53%
+21.12K
+0.59%
Jun 30, 2025
State Street Investment Management (US)
1.29M
3.78%
-17.52K
-1.34%
Jun 30, 2025
Two Sigma Investments, LP
692.64K
2.03%
+666.54K
+2554.00%
Jun 30, 2025
Nomura Investment Management Business Trust
952.11K
2.79%
-163.49K
-14.66%
Jun 30, 2025
Geode Capital Management, L.L.C.
804.65K
2.36%
+11.24K
+1.42%
Jun 30, 2025
Driehaus Capital Management, LLC
854.04K
2.51%
+75.28K
+9.67%
Jun 30, 2025
Hood River Capital Management LLC
679.85K
1.99%
-115.92K
-14.57%
Jun 30, 2025
Emerald Advisers LLC
694.97K
2.04%
-22.39K
-3.12%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Global X HealthTech ETF
4.75%
Clough Select Equity ETF
2.87%
Invesco S&P SmallCap Health Care ETF
2.75%
State Street SPDR S&P Health Care Equipment ETF
2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.47%
iShares S&P Small-Cap 600 Growth ETF
0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.58%
Ver más
Global X HealthTech ETF
Proporción4.75%
Clough Select Equity ETF
Proporción2.87%
Invesco S&P SmallCap Health Care ETF
Proporción2.75%
State Street SPDR S&P Health Care Equipment ETF
Proporción2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción1.47%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporción0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.58%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Transmedics Group Inc?

Los cinco principales accionistas de Transmedics Group Inc son:
BlackRock Institutional Trust Company, N.A. posee 4.73M acciones, lo que representa el 13.87% del total de acciones.
Fidelity Management & Research Company LLC posee 4.63M acciones, lo que representa el 13.57% del total de acciones.
The Vanguard Group, Inc. posee 3.59M acciones, lo que representa el 10.53% del total de acciones.
State Street Investment Management (US) posee 1.29M acciones, lo que representa el 3.78% del total de acciones.
Two Sigma Investments, LP posee 692.64K acciones, lo que representa el 2.03% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Transmedics Group Inc?

Los tres principales tipos de accionista de Transmedics Group Inc son:
BlackRock Institutional Trust Company, N.A.
Fidelity Management & Research Company LLC
The Vanguard Group, Inc.

¿Cuántas instituciones poseen acciones de Transmedics Group Inc (TMDX)?

A fecha de 2025Q3, 762 instituciones poseen acciones de Transmedics Group Inc, con un valor de mercado combinado de aproximadamente 37.62M, lo que representa el 110.09% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -13.93%.

¿Cuál es la mayor fuente de ganancias de Transmedics Group Inc?

El FY2025Q2, el segmento empresarial OCS Liver net revenue generó la ganancia más alta para Transmedics Group Inc, ascendiendo a 116.11M y representando el 74.26% de la ganancia total.
KeyAI